tiprankstipranks
PharmaNutra SpA (IT:PHN)
:PHN
Italy Market
Want to see IT:PHN full AI Analyst Report?

PharmaNutra SpA (PHN) Ratios

12 Followers

PharmaNutra SpA Ratios

IT:PHN's free cash flow for Q1 2026 was €0.63. For the 2026 fiscal year, IT:PHN's free cash flow was decreased by € and operating cash flow was €0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.38 2.35 2.38 2.12 2.28
Quick Ratio
2.11 2.06 2.12 1.83 2.07
Cash Ratio
0.67 0.60 0.57 0.68 0.86
Solvency Ratio
0.47 0.44 0.37 0.26 0.33
Operating Cash Flow Ratio
0.62 0.63 0.75 0.44 0.56
Short-Term Operating Cash Flow Coverage
4.61 4.20 4.61 2.87 4.30
Net Current Asset Value
€ 21.02M€ 18.91M€ 9.73M€ 646.00K€ 9.52M
Leverage Ratios
Debt-to-Assets Ratio
0.15 0.16 0.21 0.25 0.18
Debt-to-Equity Ratio
0.26 0.29 0.39 0.51 0.35
Debt-to-Capital Ratio
0.20 0.22 0.28 0.34 0.26
Long-Term Debt-to-Capital Ratio
0.15 0.17 0.23 0.29 0.21
Financial Leverage Ratio
1.72 1.76 1.89 2.07 1.97
Debt Service Coverage Ratio
-2.96 4.17 3.47 2.98 4.39
Interest Coverage Ratio
-8.60 27.86 15.94 19.58 69.19
Debt to Market Cap
0.02 0.04 0.04 0.05 0.03
Interest Debt Per Share
2.08 2.26 2.70 3.02 1.87
Net Debt to EBITDA
0.45 0.06 0.27 0.34 -0.18
Profitability Margins
Gross Profit Margin
29.41%22.56%71.28%48.45%36.17%
EBIT Margin
-6.52%23.02%24.30%23.82%28.14%
EBITDA Margin
-3.32%25.98%27.56%26.26%29.51%
Operating Profit Margin
-5.28%23.02%23.57%23.12%27.63%
Pretax Profit Margin
22.61%22.92%23.39%23.02%28.08%
Net Profit Margin
15.16%15.19%14.30%12.70%18.04%
Continuous Operations Profit Margin
15.11%15.12%14.25%12.70%18.04%
Net Income Per EBT
67.06%66.26%61.15%55.17%64.26%
EBT Per EBIT
-428.16%99.59%99.23%99.57%101.64%
Return on Assets (ROA)
16.41%15.97%14.14%11.41%15.02%
Return on Equity (ROE)
30.77%28.03%26.72%23.59%29.54%
Return on Capital Employed (ROCE)
-7.57%32.18%30.37%27.55%30.98%
Return on Invested Capital (ROIC)
-4.82%20.15%17.58%14.42%18.99%
Return on Tangible Assets
20.32%19.85%17.64%14.27%19.15%
Earnings Yield
2.46%3.85%3.18%2.35%2.50%
Efficiency Ratios
Receivables Turnover
4.82 5.14 5.07 5.26 3.85
Payables Turnover
5.59 5.13 3.60 4.54 3.15
Inventory Turnover
11.54 11.52 8.20 6.38 10.12
Fixed Asset Turnover
5.76 5.46 4.53 3.83 4.89
Asset Turnover
1.08 1.05 0.99 0.90 0.83
Working Capital Turnover Ratio
3.26 3.31 3.38 3.16 2.33
Cash Conversion Cycle
42.10 31.43 15.21 46.22 15.03
Days of Sales Outstanding
75.79 70.97 71.99 69.43 94.74
Days of Inventory Outstanding
31.63 31.68 44.53 57.22 36.08
Days of Payables Outstanding
65.32 71.22 101.31 80.44 115.79
Operating Cycle
107.42 102.65 116.51 126.66 130.82
Cash Flow Ratios
Operating Cash Flow Per Share
2.03 2.04 2.13 1.25 1.50
Free Cash Flow Per Share
1.67 1.72 1.69 -0.12 -0.90
CapEx Per Share
0.36 0.33 0.44 1.37 2.39
Free Cash Flow to Operating Cash Flow
0.82 0.84 0.79 -0.10 -0.60
Dividend Paid and CapEx Coverage Ratio
1.49 1.54 1.65 0.58 0.48
Capital Expenditure Coverage Ratio
5.69 6.24 4.82 0.91 0.62
Operating Cash Flow Coverage Ratio
1.02 0.95 0.84 0.43 0.82
Operating Cash Flow to Sales Ratio
0.14 0.15 0.18 0.12 0.17
Free Cash Flow Yield
1.87%3.16%3.11%-0.21%-1.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
40.18 25.98 31.45 42.49 40.04
Price-to-Sales (P/S) Ratio
6.16 3.95 4.50 5.40 7.23
Price-to-Book (P/B) Ratio
11.45 7.28 8.41 10.02 11.83
Price-to-Free Cash Flow (P/FCF) Ratio
53.29 31.63 32.17 -471.27 -69.33
Price-to-Operating Cash Flow Ratio
43.92 26.56 25.50 45.09 41.65
Price-to-Earnings Growth (PEG) Ratio
1.31 1.25 1.05 -2.88 4.06
Price-to-Fair Value
11.45 7.28 8.41 10.02 11.83
Enterprise Value Multiple
-185.35 15.25 16.60 20.90 24.31
Enterprise Value
853.96M 521.59M 531.39M 554.35M 598.25M
EV to EBITDA
-185.76 15.25 16.60 20.90 24.31
EV to Sales
6.16 3.96 4.58 5.49 7.17
EV to Free Cash Flow
53.28 31.75 32.70 -479.12 -68.84
EV to Operating Cash Flow
43.91 26.66 25.92 45.84 41.36
Tangible Book Value Per Share
5.20 4.89 4.05 3.30 3.04
Shareholders’ Equity Per Share
7.79 7.46 6.47 5.63 5.27
Tax and Other Ratios
Effective Tax Rate
0.33 0.34 0.39 0.45 0.36
Revenue Per Share
14.48 13.76 12.09 10.45 8.62
Net Income Per Share
2.20 2.09 1.73 1.33 1.56
Tax Burden
0.67 0.66 0.61 0.55 0.64
Interest Burden
-3.47 1.00 0.96 0.97 1.00
Research & Development to Revenue
<0.01 <0.01 0.01 0.01 <0.01
SG&A to Revenue
0.40 0.36 0.26 0.07 0.23
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.93 0.98 1.24 0.94 0.96
Currency in EUR